In Vitro Fertilization Market

In Vitro Fertilization Market by Product (Instrument [Imaging Systems, Incubators, Cryosystems, IVF Cabinet, Sperm Separation Devices, Ovum Aspiration Pump, and Others] and Reagent), End-User (Hospitals, Fertility Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increasing cases of infertility and delay in pregnancies.

The in vitro fertilization market is estimated to grow at a CAGR of 6.31% during the forecast period from 2024 to 2030. The growing demand for in vitro fertilization (IVF) is driven by several factors, including the rising prevalence of infertility among men and women, delayed childbearing, and various sexual health challenges. Additionally, advancements in IVF technologies, such as the increasing success rates and the adoption of innovative treatments like intracytoplasmic sperm injection (ICSI), are significantly boosting market growth. The escalating obesity rates, which often impact fertility, further contribute to the rising need for IVF treatments. Moreover, the market is benefiting from a surge in product launches, regulatory approvals, and ongoing innovation in fertility solutions. These factors collectively are expected to propel the growth of the IVF market during the forecast period from 2024 to 2030.

In Vitro Fertilization Market Dynamics:

The global prevalence of infertility and its associated risk factors is significantly driving the growth of the in vitro fertilization (IVF) market. Infertility impacts a considerable percentage of couples worldwide, intensifying the demand for fertility-related products and services. According to the Organization for Economic Co-operation and Development (OECD) 2023 data, total fertility rates (TFR) in many countries were below the replacement level of 2.1 in 2021, with South Korea at 0.81, France at 1.80, Sweden at 1.67, and Switzerland at 1.51. Similarly, 2020 data reveals low TFRs in countries such as Australia (1.58), Canada (1.50), China (1.70), the United States (1.64), and Japan (1.33). The World Health Organization (WHO) 2023 further highlights that one in six individuals of reproductive age globally experiences infertility, underscoring the pressing need for effective solutions.

In response to these challenges, governments and organizations have launched initiatives to promote reproductive health awareness and address infertility issues. Campaigns such as Pinnacle Fertility's Save IVF and Oasis Fertility's Infertility Knows No Gender have played pivotal roles in educating the public about treatment options and advocating for family-building support. Additionally, advancements in IVF technology, including the introduction of innovative procedures like Needle-Free IVF by the Rejuvenating Fertility Center (RFC) in August 2022, are revolutionizing treatment. This procedure utilizes oral and nasal fertility medications, offering a less invasive approach that gently stimulates ovarian activity to yield higher-quality eggs.

The increasing availability of advanced IVF facilities and cutting-edge technologies worldwide further propels market growth. However, challenges such as false positive results, limited insurance coverage in emerging markets, and other barriers could constrain expansion. Despite these hurdles, the cumulative impact of rising infertility rates, supportive campaigns, and technological advancements is expected to drive the IVF market significantly during the forecast period from 2024 to 2030.

In Vitro Fertilization Market Segment Analysis:

In Vitro Fertilization Market by Product (Instrument [Imaging Systems, Incubators, Cryosystems, IVF Cabinet, Sperm Separation Devices, Ovum Aspiration Pump, and Others] and Reagent), End-User (Hospitals, Fertility Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

The sperm separation devices segment is poised to capture a significant share of revenue in the in vitro fertilization (IVF) market by 2023, driven by its critical role and advantages in assisted reproductive technologies (ART). These devices are integral to procedures like IVF and artificial insemination, providing purified sperm samples essential for successful outcomes.

The adoption of advanced technologies, such as sperm syringes, is a key factor bolstering this segment's growth. Sperm syringes enable a highly efficient and parallelized sorting mechanism by maximizing the contact area of semen samples with selection events. This approach facilitates the retrieval of high-quality sperm, often reducing the need for more invasive procedures like intracytoplasmic sperm injection (ICSI). By offering sufficient quantities of high-quality sperm, sperm syringes support less invasive ART methods, such as droplet-based IVF and intrauterine insemination (IUI).

This innovation not only reduces the clinical burden associated with invasive techniques but also improves long-term health outcomes for infants conceived through ART. As a viable alternative to ICSI, sperm syringes contribute to enhanced patient experiences and outcomes, further driving their adoption across fertility clinics.

Given these advantages and their growing applications, the sperm separation devices segment is expected to experience substantial growth, contributing significantly to the overall expansion of the IVF market during the forecast period.

North America is expected to dominate the overall In Vitro Fertilization Market:

North America is projected to hold the largest share of the in vitro fertilization (IVF) market in 2023, driven by a combination of key factors fostering market growth. These include the rising prevalence of infertility-related conditions such as polycystic ovary syndrome (PCOS), increasing standardization of fertility procedures, government initiatives for sperm and egg storage, and favorable regulatory reforms. Additionally, a growing incidence of infertility in both sexes, the presence of leading industry players, the rise of single women and same-sex couples seeking parenthood, and robust product development activities contribute to the region's market dominance.

The Centers for Disease Control and Prevention (CDC) 2023 highlights that in the United States, approximately 19% of married women aged 15 to 49 years with no prior births experience infertility after one year of trying. Furthermore, about 26% face impaired fecundity, with difficulties conceiving or carrying a pregnancy to term. In Canada, the fertility rate dropped to a record low of 1.40 children per woman in 2020, as reported by Statistics Canada. Similarly, Mexico’s fertility rate was reported at 1.8 children per woman in 2022, with projections suggesting further declines to 1.72 by 2050, according to OECD data. These figures underscore a consistent increase in infertility across North America, fueling the demand for IVF solutions.

The adoption of strategic business initiatives by companies further supports market growth. For instance, Cooper Companies’ acquisition of Generate Life Sciences in December 2021 for $1.6 billion expanded its offerings in donor eggs and sperm, fertility cryopreservation, and stem cell storage. This move enhanced CooperSurgical's ability to provide comprehensive fertility services and products, strengthening its market presence.

Collectively, these factors rising infertility rates, technological advancements, supportive government policies, and strategic corporate initiatives are expected to drive the growth of the IVF market in North America during the forecast period from 2024 to 2030.

Key In Vitro Fertilization Companies In The Market:

Some of the key in-vitro fertilization companies operating in the market include CooperSurgical, Inc., Cook Medical, FUJIFILM Holdings America Corporation, Genea Biomedx, Hamilton Thorne, Merck KGaA, SRL Diagnostic, Nikon Instruments Inc., Thermo Fisher Scientific Inc., Vitrolife, Sysmex Corporation, Rocket Medical plc., Menicon Co. Ltd., LensHooke, Promega Corporation, and others.

Recent Developmental Activities in the In Vitro Fertilization Market:

• In May 2023, AIVF, the developer of AI-based solutions for IVF clinics, and Genea Biomedx launched an integrated system. The new integrated solution provides widespread access to individualized, improved IVF care by connecting Genea Biomedx's Geri time-lapse incubator with AIVF's innovative EMA AI platform.
• In December 2022, Kindbody launched a state-of-the-art clinic and in vitro fertilization (IVF) lab in Dallas to meet the increasing demand for world-class fertility care and comprehensive family-building benefits by patients and employers in the area.
• In March 2022, Malta, in collaboration with Pera Labs’s commercialization advisors at the University City Science Center, started the research and development of an AI-powered sperm and egg selection technology for fertility treatments. Pera Labs’s Malta operations are accelerated by the EUR 800,000 (USD 8,83,040) of financial support from Malta Enterprise, coupled with Pera Labs’s financing.

Key Takeaways from the In Vitro Fertilization Market Report Study

• Market size analysis for current in vitro fertilization market size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the global in vitro fertilization market.
• Various opportunities available for the other competitors in the in vitro fertilization market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current in vitro fertilization market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for in vitro fertilization market growth in the coming future?

Target Audience Who Can be benefited from this In Vitro Fertilization Market Report Study

• In Vitro Fertilization product providers
• Research organizations and consulting companies
• In Vitro Fertilization-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in In Vitro Fertilization
• Various End-users who want to know more about the in vitro fertilization market and the latest technological developments in the in vitro fertilization market.